Email this article Late reproductive age and modern technology
- Authors: - -
- Issue: Vol 21, No 4 (2019)
- Pages: 27-32
- Section: Articles
- URL: https://medbiosci.ru/2079-5831/article/view/33478
- DOI: https://doi.org/10.26442/20795696.2019.4.190563
- ID: 33478
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Инструкция по медицинскому применению лекарственного препарата Дюфастон® 10 мг, таблетки покрытые пленочной оболочкой, 26.02.2018.
- Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C. Use of oral dydrogesterone for luteal phase support in fresh IVF cycles is associated with an increase in live birth rate: an integrated individual patient data analysis of the lotus phase iii trial program. Fertil Steril 2018;110(4):e90.
- Pandian R.U. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas 2009; 65 Suppl 1: S47-S50.
- Kumar A. et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial Fertility and Sterility 2014;5; 0015-0282.
- Coomarasamy A. et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. New England Journal of Medicine, 2019; 380:1815-1824. doi: 10.1056/NEJMoa1813730.
- Coomarasamy A. et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med. 2015 Nov 26;373(22):2141-8
- Тетруашвили Н.К., Агаджанова А.А. Дидрогестерон в лечении угрожающего и привычного выкидыша // Медицинский совет, 2018, №13. - С. 34-38.
- Прохоренко Н.Ф. Демографический потенциал: дополнительные аспекты // ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ. 2019. Т. 5, № 2. С.22-47.
Supplementary files
